Loading provider…
Loading provider…
Gynecologic Oncology Physician in Mountain View, CA
NPI: 1295894673Primary Practice Location
El Camino Hospital - Melchor Pavilion
2490 Hospital Drive, Mountain View, CA
Primary Employer
Palo Alto Medial Foundation
sutterhealth.org
HQ Phone
Get M.D. Albert's Phone Numberphone_androidMobile
Get M.D. Albert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1989 - 2027
IL State Medical License
1992 - 2005
NV State Medical License
2000 - 2005

American Board of Obstetrics and Gynecology
Obstetrics & Gynecology

American Board of Obstetrics and Gynecology
Gynecologic Oncology
Cedars-Sinai Medical Center
Residency • Obstetrics and Gynecology
1988 - 1992
Feinberg School of Medicine
feinberg.northwestern.edu
Medical School
Until 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 88 | 104 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 37 | 45 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 36 | 36 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 18 | 20 |
Authors: Wei-Chien Lin
Journal: Gynecol Oncol
Commenting on “future directions in the surgical management of ovarian cancer”
Authors: Nick M. Spirtos, Albert L. Pisani, N.Dwight Chen, Peter Lim
What Is the Role of Reassessment Laparoscopy in the Management of Gynecologic Cancers in 1995
Authors: Laila Muderspach, Beth Karlan, Frank Cirisano
Publication Date: 1996-03
Lead Sponsor: Gynecologic Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, OTHER: Placebo Administration, DRUG: Metformin Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, DRUG: Letrozole, DRUG: Topotecan, DRUG: Tamoxifen Citrate, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, DRUG: Trametinib Dimethyl Sulfoxide
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Dasatinib